MICREOS HUMAN HEALTH BV has a total of 64 patent applications. It decreased the IP activity by 16.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are CHILDREN S HOSPITAL LOS ANGELE, NEXBIO INC and WARENIUS HILMAR M.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | United States | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | Australia | 6 | |
#5 | Canada | 6 | |
#6 | China | 6 | |
#7 | Republic of Korea | 5 | |
#8 | Singapore | 5 | |
#9 | Brazil | 4 | |
#10 | Hong Kong | 4 | |
#11 | Israel | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement | |
#5 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Enzymes | |
#5 | Peptides | |
#6 | Analysing materials | |
#7 | Preservation of human bodies | |
#8 | Food preservation | |
#9 | Special foods | |
#10 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Eichenseher Fritz | 46 |
#2 | Loessner Martin Johannes | 30 |
#3 | Offerhaus Mark Leonard | 21 |
#4 | Herpers Bjorn Lars | 7 |
#5 | Fritz Eichenseher | 7 |
#6 | Martin Johannes Loessner | 5 |
#7 | Eitchenseher Fritz | 1 |
Publication | Filing date | Title |
---|---|---|
US2019374621A1 | Combination treatment for atopic dermatitis | |
EP3692149A1 | Treatment of a condition associated with infection with an oncogenic bacterium | |
KR20190071720A | Combination of vasoconstrictive and antimicrobial treatment of injection | |
WO2016142445A2 | Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection | |
EP3144387A1 | A novel endolysin polypeptide | |
WO2015005787A1 | Combination treatment for atopic dermatitis | |
BR112014027629A2 | polypeptide mixtures with antibacterial activity | |
CA2834924A1 | Endolysin polypeptide of a s. aureus bacteriophage |